BAB V KESIMPULAN DAN SARAN
5.2 Saran
1. Untuk peneliti selanjutnya diharapkan menggunakan database jurnal yang lebih bervariatif dan menggunakan literatur yang sesuai dengan variabel yang ingin diteliti.
2. Untuk peneliti selanjutnya diharapkan mengembangkan penelitian mengenai hubungan patomekanisme dan prognosis terhadap penatalaksanaan pada keloid.
81
DAFTAR PUSTAKA
1. Nangole FW, Agak GW. Keloid pathophysiology: fibroblast or inflammatory disorders?: Pathophysiology of Keloids. JPRAS Open [Internet]. 2019;22:44–
54
2. Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. The Keloid Disorder:
Heterogeneity, Histopathology, Mechanisms and Models. Front Cell Dev Biol.
2020;8(May).
3. Huang C, Ogawa R. Keloidal pathophysiology: Current notions. Scars, Burn Heal. 2021;7:205951312098032.
4. Elazhary E, Abd Al-Salam F, Abd El-Hafiz H, Maghraby H. Updates on keloid scar pathogenesis, assessment and treatment modalities. J Recent Adv Med.
2022;3(1):75–86.
5. Jannah A R, Listyawan M Y, Perdanakusuma, D S. Epidemiologi Keloid Di RSUD Dr. Soetomo Surabaya Periode 2017 – 2018. J Kesehat Soetomo [Internet]. 2021 (diakses pada 24 Mei 2022);8(2):79–84. ISSN: 2407-2486.
Diunduh di URL: https://rsudrsoetomo.jatimprov.go.id/wp-content/uploads/2022/02/1.-JKS-Juni-2021.pdf
6. Ojeh N, Bharatha A, Gaur U, Forde AL. Keloids: Current and emerging therapies. Scars, Burn Heal. 2020;6:205951312094049.
7. Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3).
8. Sinto L. Scar Hipertrofik dan Keloid: Patofisiologi dan Penatalaksanaan.
Cermin Dunia Kedokt. 2018;45(1):29–32.
9. Ogawa R. Keloids and Hypertrophic Scars Can Now Be Treated Completely by Multimodal Therapy, Including Surgery, Followed by Radiation and Corticosteroid Tape/Plaster. Intech Open [Internet]. 2019;11(scars):13
10. Prihharsanti CHN, Setyarto MR, Bramantyo DF. Radiotherapy for Recurrent Keloid: A Case Report. J Biomed Transl Res. 2020;6(3):89–91.
11. Gauglitz GG. Textbook on Scar Management. Textbook on Scar Management.
2020. Diunduh di URL:
https://link.springer.com/content/pdf/10.1007/978-3-030-44766-3.pdf
12. Kant SB, van den Kerckhove E, Colla C, Tuinder S, van der Hulst RRWJ, Piatkowski de Grzymala AA. A new treatment of hypertrophic and keloid scars with combined triamcinolone and verapamil: A retrospective study. Eur J Plast Surg. 2018;41(1):69–80.
13. Gold MH, Nestor MS, Berman B, Goldberg D. Assessing keloid recurrence following surgical excision and radiation. Burn Trauma. 2020;8:1–7.
14. David Jansen JAM. Keloids. Medscape. 2021;1–11. Diunduh di URL:
https://emedicine.medscape.com/article/1298013-overview
15. Hsu CK, Lin HH, Harn HIC, Hughes MW, Tang MJ, Yang CC. Mechanical forces in skin disorders. J Dermatol Sci [Internet]. 2018;90(3):232–40
16. Jones ME, McLane J, Adenegan R, Lee J, Ganzer CA. Advancing Keloid Treatment: A Novel Multimodal Approach to Ear Keloids. Dermatologic Surg.
2017;43(9):1164–9
17. Sarah McGinty WJS. Keloid [Internet]. StatPearls Publishing LLC; 2021. 23 p 18. Shaheen AA. Risk Factors of Keloids: A Mini Review. Austin J Dermatology.
2017;4(2):1–5
19. Hinojosa JA, Pandya AG. The Importance of Patient Registries in Skin of Color. J Investig Dermatology Symp Proc. 2017;18(2):S31–3
20. Glass DA. Current Understanding of the Genetic Causes of Keloid Formation.
J Investig Dermatology Symp Proc [Internet]. 2017;18(2):S50–3
21. Shaheen A. Comprehensive Review of Keloid Formation. J Clin Res Dermatology. 2017;4(5):1–18
22. He Y, Deng Z, Alghamdi M, Lu L, Fear MW, He L. From genetics to epigenetics: new insights into keloid scarring. Cell Prolif. 2017;50(2):1–8 23. Ghazawi FM, Zargham R, Gilardino MS, Sasseville D, Jafarian F. Insights into
the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ?
Adv Ski Wound Care. 2018;31(1):582–95
24. Kiritsi D, Nyström A. The role of TGFβ in wound healing pathologies. Mech Ageing Dev [Internet]. 2018;172:51–8
25. Lee HJ, Jang YJ. Recent understandings of biology, prophylaxis and treatment
strategies for hypertrophic scars and keloids. Int J Mol Sci. 2018;19(3)
26. Betarbet U, Blalock TW. Keloids: A review of etiology, prevention, and treatment. J Clin Aesthet Dermatol. 2020;13(2):33–43
27. Forbat E, Ali FR, Al-Niaimi F. Treatment of keloid scars using light-, laser- and energy-based devices: a contemporary review of the literature. Lasers Med Sci. 2017;32(9):2145–54
28. Memariani H, Memariani M, Moravvej H, Shahidi-Dadras M. Emerging and Novel Therapies for Keloids. Sultan Qaboos Univ Med J [SQUMJ].
2021;21(1):e22-33
29. Xu J, Yang E, Yu NZ, Long X. Radiation therapy in keloids treatment: History, strategy, effectiveness, and complication. Chin Med J (Engl).
2017;130(14):1715–21
30. Wardani, Fania Ayu; Perdanakusuma, David Sontani; Indramaya IM. Profile of Working-Age Patients with Keloid and Hypertrophic Scar at Dr. Soetomo General Hospital Surabaya in 2014-2017. JUXTA J Ilm Mhs Kedokt Univ Airlangga. 2021;12(2):77–83
31. da Cunha Colombo Tiveron LR, da Silva IR, da Silva MV, Peixoto AB, Rodrigues DBR, Rodrigues V. High in situ mRNA levels of IL-22, TFG-β, and ARG-1 in keloid scars. Immunobiology [Internet]. 2018;223(12):812–7 32. Khattab FM, Samir MA. Correlation between serum IL 37 levels with keloid
severity. J Cosmet Dermatol. 2020;19(9):2428–31
33. Limandjaja GC, van den Broek LJ, Waaijman T, Breetveld M, Monstrey S, Scheper RJ, et al. Reconstructed human keloid models show heterogeneity within keloid scars. Arch Dermatol Res [Internet]. 2018;310(10):815–26 34. Zhu XJ, Li WZ, Li H, Fu CQ, Liu J. Association of interleukin-6 gene
polymorphisms and circulating levels with keloid scars in a Chinese han population. Genet Mol Res. 2017;16(2):1–8
35. Mohamed R, Elawadi AA, Al-Gendi R, Al-Mohsen S, Wani S, Wafa A. The outcome of postoperative radiation therapy following plastic surgical resection of recurrent ear keloid: a single institution experience. J Egypt Natl Canc Inst [Internet]. 2022;34(1):0–8
36. Jiang WQ, Guo LL, Wu H, Ying J, Yang Z, Wei BH, et al. Use of a smartphone for imaging, modelling, and evaluation of keloids. Burns [Internet].
2020;46(8):1896–902
37. Song K xin, Liu S, Zhang M zi, Liang W zhong, Liu H, Dong X hang, et al.
Hyperbaric oxygen therapy improves the effect of keloid surgery and radiotherapy by reducing the recurrence rate. J Zhejiang Univ Sci B.
2018;19(11):853–62
38. Lee YI, Kim J, Yang CE, Hong JW, Lee WJ, Lee JH. Combined Therapeutic Strategies for Keloid Treatment. Dermatologic Surg. 2019;45(6):802–10 39. Aggarwal A, Ravikumar BC, Vinay KN, Raghukumar S, Yashovardhana DP.
A comparative study of various modalities in the treatment of keloids. Int J Dermatol. 2018;57(10):1192–200
40. Ahmad M, Ahmad H, Khattak MR, Shah KA, Javed N, Shah SJA, et al.
Postoperative single versus multiple fractions high-dose rate iridium-192 surface mould brachytherapy for keloid treatment: A comparative study. J Radiother Pract. 2018;17(1):60–5
LAMPIRAN
Lampiran 1 Surat Etik Penelitian
Lampiran 2 Surat Izin Penelitian
Lampiran 3 Kartu Bimbingan Mahasiswa
Lampiran 4 Jurnal